Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3228125
Max Phase: Preclinical
Molecular Formula: C20H32N4O13
Molecular Weight: 536.49
Molecule Type: Small molecule
Associated Items:
ID: ALA3228125
Max Phase: Preclinical
Molecular Formula: C20H32N4O13
Molecular Weight: 536.49
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: N[C@@H]1C[C@H](N)[C@@H](O[C@H]2O[C@@H]3CNC(=O)O[C@H]3[C@H](O)[C@H]2O)[C@H](O)[C@H]1O[C@H]1O[C@H](CO)[C@@H](O)[C@@H]2NC(=O)O[C@@H]12
Standard InChI: InChI=1S/C20H32N4O13/c21-4-1-5(22)14(35-18-16-8(24-20(31)37-16)9(26)7(3-25)33-18)12(29)13(4)34-17-11(28)10(27)15-6(32-17)2-23-19(30)36-15/h4-18,25-29H,1-3,21-22H2,(H,23,30)(H,24,31)/t4-,5+,6+,7+,8-,9+,10+,11+,12-,13+,14-,15+,16+,17+,18+/m0/s1
Standard InChI Key: PCYZTGDESDMBLC-JXLUWRRSSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 536.49 | Molecular Weight (Monoisotopic): 536.1966 | AlogP: -5.71 | #Rotatable Bonds: 5 |
Polar Surface Area: 266.77 | Molecular Species: BASE | HBA: 15 | HBD: 9 |
#RO5 Violations: 3 | HBA (Lipinski): 17 | HBD (Lipinski): 11 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 11.71 | CX Basic pKa: 9.34 | CX LogP: -5.15 | CX LogD: -7.46 |
Aromatic Rings: 0 | Heavy Atoms: 37 | QED Weighted: 0.16 | Np Likeness Score: 1.74 |
1. Kumar V, Remers WA.. (1979) Aminoglycoside antibiotics. 2. N,N-Dialkylkanamycins., 22 (4): [PMID:107311] [10.1021/jm00190a015] |
Source(1):